Tower Research Capital LLC (Trc) Ovid Therapeutics Inc. Transaction History
Tower Research Capital LLC (Trc)
- $4.07 Billion
- Q1 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 24,135 shares of OVID stock, worth $18,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,135
Previous 4,383
450.65%
Holding current value
$18,101
Previous $14,000
421.43%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding OVID
# of Institutions
82Shares Held
43.2MCall Options Held
5.9KPut Options Held
300-
Eco R1 Capital, LLC San Francisco, CA6.12MShares$4.59 Million0.53% of portfolio
-
Rubric Capital Management LP New York, NY5.32MShares$3.99 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.2MShares$3.15 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.89 Million0.35% of portfolio
-
Madison Avenue Partners, LP New York, NY3.65MShares$2.74 Million2.22% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $52.8M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...